Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment
Titel:
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment
Auteur:
Madan, Ravi A. Schmidt, Keith T. Karzai, Fatima Peer, Cody J. Cordes, Lisa M. Chau, Cindy H. Steinberg, Seth M. Owens, Helen Eisner, Joel Moore, William R. Dahut, William L. Gulley, James L. Figg, William D.